Jul 23
FDA advisory panel, stacked with Kennedy appointees, votes to allow compounding of six unapproved peptides
The FDA's Pharmacy Compounding Advisory Committee recommended removing BPC-157, TB-500, KPV, MOTS-c, semax, and epitalon from a banned list, opening the door for compounding pharmacies to produce them despite agency staff warnings about safety and lack of efficacy evidence.
